Nestle to enter traditional Chinese medicine (TCM) industry

On Nov 29, Nestle, the World’s largest food company, announced its move into China’s traditional Chinese medicine (TCM) industry. Nestle is establishing a joint venture with the Chinese pharmaceutical company, Chi-Med, which is owned by Li Ka-Shing, the most successful entrepreneur in China. The new...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email Thank you!

Related Research

Proteon Pharmaceuticals raises $24.6 million for rolling out bacteriophage therapies globally

News Commentary | August 13, 2021

The round was co‑led by Nutreco and Aqua‑Spark and joined by PFR Life Science, Montis Capital, Seventure Partners, and others. Proteon will use the funds for the commercialization and global rollout of its bacteriophage therapies for livestock and to develop new solutions to prevent mastitis in ... Not part of subscription


Company Profile | February 28, 2022

Since we last spoke with Phagelux in 2018, the company split into two separate entities: Phagelux Skin Sciences, which develops products for human health, and Phagelux AgriHealth, which develops products for animal health, aquaculture, plant health, and food safety Through the acquisition of ... Not part of subscription

Brightseed raises USD 68 million to accelerate discovery and novel functional ingredient commercialization

News Commentary | May 11, 2022

Brightseed secured USD 68 million in funding led by Temasek to allow their artificial intelligence‑backed discovery tool "Forager" to continue mining healthful compounds in waste streams and grow partnerships like the one established with Danone. The biggest change will come if the company is able ... Not part of subscription